Harrow Reaffirms $270-$280mln FY23 Guidance, Doubles VEVYE Sales Force

lunes, 2 de febrero de 2026, 7:34 am ET1 min de lectura
HROW--

• Harrow reaffirms 2025 revenue guidance of $270-$280 million. • VEVYE sales force doubles. • IHEEZO commercial expansion underway in office-based setting. • TRIESENCE commercial footprint doubles in surgical-based setting. • OneHarrow Initiative unifies branding under Harrow. • Patrick W. Sullivan promoted to Chief Commercial Officer. • MELT-300 and MELT-210 programs on track for NDA filings. • ImprimisRx settles with California Board of Pharmacy.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios